Effect of selected flavones on cancer and endothelial cells

General Physiology and Biophysics

Volumn 29, Issue 2, 2010, Pages 134-143

  Pilátová, Martina ^a   Stupáková, Viktória ^a   Varinská, Lenka ^a   Šarišský, Marek ^a   Mirossay, Ladislav ^a   Miroššay, Andrej ^a   Gál, Peter ^a   Kraus, Vladimír ^a   Dianišková, Katarína ^a   Mojžiš, Ján ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

3 Hydroxyflavone; Antiangiogenic; Antiproliferative; Chrysin; Quercetin

Indexed keywords

3 HYDROXYFLAVONE; CHRYSIN; DNA; FLAVONE; GELATINASE A; GELATINASE B; QUERCETIN; 3-HYDROXYFLAVONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FLAVONE DERIVATIVE; FLAVONOID; MMP2 PROTEIN, HUMAN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DNA FRAGMENTATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LUNG CARCINOMA; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELLS, CULTURED; DNA FRAGMENTATION; ENDOTHELIAL CELLS; FLAVONES; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; QUERCETIN;

EID: 77954126617     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_02_134     Document Type: Article

References (34)

1. Alfa M., Mateos R., Ramos S., Lecumberri E., Bravo L., Goya L. (2006): Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). Eur. J. Nutr. 45, 19-28; doi:10.1007/s00394- 005-0558-7
2. Cipák L., Rauko P., Miadoková E., Cipáková I., Novotný L. (2003): Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leuk. Res. 27, 65-72; doi:10.1016/S0145-2126(02)00063-2
3. Chan M. M., Fong D., Soprano K. J., Holmes W. F., Heverling H. (2003): Inhibition of growth and sensitization to cisplatin- mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J. Cell. Physiol. 194, 63-70; doi:10.1002/jcp.10186
4. Choi J. A., Kim J. Y., Lee J. Y., Kang C. M., Kwon H. J., Yoo Y. D., Kim T. W., Lee Y. S., Lee S. J. (2001): Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol. 19, 837-844
5. Delgado M. E., Haza A. I., Arranz N., Garcia A., Morales P. (2008): Dietary polyphenols protect against N-nitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells. Eur. J. Nutr. 47, 479-490; doi:10.1007/ s00394-008-0751-6
6. Duthie G. G., Gardner P. T., Kyle J. A. M. (2003): Plant polyphenols: are they the new magic bullet? Proc. Nutr. Soc. 62, 599-603; doi:10.1079/PNS2003275
7. Gupta K., Panda D. (2002): Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity. Biochemistry 41, 13029-13038; doi:10.1021/bi025952r (Pubitemid 35215787)
8. Hakimuddin F., Tiwari K., Paliyath G., Meckling K. (2008): Grape and wine polyphenols down-regulate the expression of signal transduction genes and inhibit the growth of estrogen receptor-negative MDA-MB231 tumors in nu/nu mouse xenografts. Nutr. Res. 28, 702-713; doi:10.1016/ j.nutres.2008.06.009
9. Jaffe E. A., Nachman R. L., Becker C. G., Ninick C. R. (1973): Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunolologic criteria. J. Clin. Invest. 11, 2745-2756; doi:10.1172/JCI107470
10. Kandaswami C., Lee L. T., Lee P. P., Hwang J. J., Ke F. C., Huang Y. T., Lee M.T. (2005): The antitumor activities of flavonoids. In Vivo 19, 895-909
11. Kawaii S., Tomono Y., Katase E., Ogawa K., Yano M. (1999): Antiproliferative activity of flavonoids on several cancer cell lines. Biosci. Biotechnol. Biochem. 6, 896-899; doi:10.1271/bbb.63.896
12. Kim M. H. (2003): Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J. Cell. Biochem. 89, 529-538; doi:10.1002/ jcb.10543
13. Kravtsov V. D., Greer J. P., Whitlock J. A., Koury M. J. (1998): Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias. Blood 92, 968-980
14. Kuntz S., Wenzel U., Daniel H. (1999): Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38, 133-142; doi:10.1007/s003940050054
15. Lamson D. W., Brignall M. S. (2000): Antioxidants and cancer, part 3: quercetin. Altern. Med. Rev. 5, 196-208
16. Li W. X., Cui C. B., Cai B., Wang H. Y., Yao X. S. (2005): Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells. J. Asian Nat. Prod. Res. 7, 615-626; doi:10.1080/ 10286020310001625085
17. Ma L., Feugang J. M., Konarski P., Wang J., Lu J., Fu S., Ma B., Tian B., Zou C., Wang Z. (2006): Growth inhibitory effects of quercetin on bladder cancer cell. Front. Biosci. 11, 2275-2285; doi:10.2741/1970
18. Marin V., Kaplanski G., Gres S., Farnarier C., Bongrand P. (2001): Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods 254, 183-190; doi:10.1016/S0022-1759(01) 00408-2 (Pubitemid 32530758)
19. Martínez C., Yàñez J., Vicente V., Alcaraz M., Benavente-García O., Castillo J., Lorente J., Lozano J. A. (2003): Effects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-a melanocyte cell lines: influence of the sequential oxidation state of the flavonoid skeleton. Melanoma Res. 13, 3-9; doi:10.1097/00008390- 200302000-00002 (Pubitemid 36269807)
20. Martínez-Poveda B., Quesada A. R., Medina M. A. (2005): Hypericin in the dark inhibits key steps of angiogenesis in vitro. Eur. J. Pharmacol. 516, 97-103; doi:10.1016/j.ej- phar.2005.03.047
21. Mojzis J., Varinska L., Mojzisova G., Kostova I, Mirossay L. (2008): Antiangogenic effect of flavonoids and chalcones. Pharmacol. Res. 57, 259-265; doi:10.1016/j.phrs.2008.02.005
22. Mojzisova G., Mojzis J. (2008): Flavonoids and their potential health benefits: relation to heart diseases and Ccncer. In: Recent Progress in Medicinal Plant. (Vol. 21). Phytopharmacology and Therapeutic Values III. (Eds. Singh V. K and Govil J. N.), pp. 105-129, Studium Pres LLC, Houston, Texas, USA
23. Mojzisova G., Kuchta M. (2001): Dietary flavonoids and risk of coronary heart disease. Physiol. Res. 50, 529-535
24. Morrow D. M., Fitzsimmons P. E., Chopra M., McGlynn H. (2001): Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat. Res. 480-481, 269-276; doi:10.1016/ S0027-5107(01)00184-1
25. Mosmann T. (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63; doi:10.1016/0022- 1759(83)90303-4
26. Newcomb E. W., Ali M. A., Schnee T., Lan L., Lukyanov Y., Fowkes M., Miller D. C., Zagzag D. (2005): Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1 alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy. Neuro Oncol. 7, 225-235; doi:10.1215/S1152851704000997 (Pubitemid 41079132)
27. Pouget C., Lauthier F., Simon A., Fagnere C., Basly J. P., CDelage C. Chulia A. J. (2001): Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. Bioorg. Med. Chem. Lett. 11, 3095-3097; doi:10.1016/S0960- 894X(01)00617-5
28. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. (2003): Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534; doi:10.1002/med.10033
29. Sivoňová M., Žitňanová I., Horáková L'., Štrosová M., Muchová J., Balgavý P., Dobrota D., Ďuračková Z. (2006): The combined effect of pycnogenol with ascorbic acid and trolox on the oxidation of lipids and proteins. Gen. Physiol. Biophys. 25, 379-396
30. Tan W. F., Lin L. P., Li M. H., Zhang Y. X., Tong Y. G., Xiao D., Ding J. (2003): Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur. J. Pharmacol. 459, 255-262; doi:10.1016/S0014-2999(02)02848-0
31. van Rijn J., van den Berg J. (1997): Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clin. Cancer Res. 3, 1775-1779
32. Weng M. S., Ho Y. S., Lin J.K. (2005): Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/ Cip1 expression: involvement of p38 mitogen-activated protein kinase. Biochem. Pharmacol. 69, 1815-1827; doi:10.1016/j.bcp.2005.03.011
33. Yáñez J., Vicente V., Alcaraz M., Castillo J., Benavente-García O., Canteras M., Teruel J. A. (2004): Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr. Cancer 49, 191-199; doi:10.1207/ s15327914nc4902-11 (Pubitemid 39487879)
34. Zhang T., Chen X., Qu L., Wu J., Cui R., Zhao Y. (2004): Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg. Med. Chem. 12, 6097-6105; doi:10.1016/j.bmc.2004.09.013